| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner, Passive Investor
1 company
Levin Capital Strategies, L.P. is a 10% Owner, Passive Investor at LAB. Recent filings cover 153 purchases and 0 sales. Those positions are worth an estimated $130K at current prices.
Levin Capital Strategies, L.P.'s largest disclosed position is in LAB as 10% Owner, Passive Investor, worth about $130K. Net of sales, the recent Form 4 record there shows accumulation of 3,370,360 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 20,380 | $5.71 | $116,305.38 | - | |
| Nov 17, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 6,880 | $5.05 | $34,744.00 | - | |
| Nov 9, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 25,000 | $5.12 | $127,975.00 | +0.2% | |
| Nov 8, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 54,900 | $5.26 | $288,773.90 | +0.3% | |
| Oct 25, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 4,227 | $5.42 | $22,916.68 | - | |
| Oct 23, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 22,363 | $5.47 | $122,305.48 | +0.2% | |
| Oct 19, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 60,000 | $4.55 | $273,000.00 | +0.6% | |
| Oct 17, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 144,200 | $4.59 | $662,497.98 | +0.7% | |
| Oct 10, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 95,843 | $4.57 | $437,997.73 | +0.5% | |
| Sep 12, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 60,000 | $5.25 | $314,700.00 | +0.5% |